Related Experiment Video
Updated: Feb 16, 2026

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis
Published on: May 22, 2018
Light-Up Nonthiolated Aptasensor for Low-Mass, Soluble Amyloid-β40 Oligomers at High Salt Concentrations
Chunyan Deng1, Hui Liu1, Manman Zhang1
1College of Chemistry and Chemical Engineering, Central South University , Changsha 410083, Hunan, PR China.
Abstract:
Herein, a light-up nonthiolated aptasensor was developed for low-mass, soluble amyloid-β40 oligomers (LS-Aβ40-O). Au nanoparticles (AuNP) were employed as colorimetric probes, and the nonthiolated aptamers (Apt) were adsorbed on AuNP surfaces, acting as binding elements for LS-Aβ40-O. The aggregation of AuNPs was induced when Apt-modified AuNPs (Apt@AuNPs) were under high-salt conditions. However, upon the addition of LS-Aβ40-O into the Apt@AuNP solution, the salt tolerance of the AuNPs was greatly enhanced. Further studies confirmed that the formed LS-Aβ40-O-Apt complex attached onto the AuNP surfaces via interactions between LS-Aβ40-O and Au, which led to electrostatic and steric stabilization of the AuNPs under high-salt conditions. On the basis of this outcome, a sensitive light-up nonthiolated aptasensor for LS-Aβ40-O was achieved with a detection limit of 10.0 nM and a linear range from 35.0 to 700 nM in a 175 mM NaCl solution. Cerebrospinal-fluid (CSF) samples from healthy persons and Alzheimer's disease (AD) patients were successfully distinguished by using this proposed method. The concentrations of LS-Aβ40-O in the CSF of AD patients were of nanomolar grade, but there was no detectable LS-Aβ40-O in those of the healthy persons. This work provides a new insight into the interaction between Apt@AuNPs and Aβ40-O and also develops a simple, rapid, highly selective and sensitive, and applicable method for LS-Aβ40-O detection in real CSF samples, which is significant for the diagnosis of AD.
More Related Videos
10:19Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps
Published on: August 14, 2016
06:34A Tailored HPLC Purification Protocol That Yields High-purity Amyloid Beta 42 and Amyloid Beta 40 Peptides, Capable of Oligomer Formation
Published on: March 27, 2017
Related Concept Videos
Factors Affecting Solubility
Solubility of Ionic Compounds
Solubility Equilibria
The...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Determining the pH of Salt Solutions
Responses to Salt Stress